Genmab | GEN - Валовая прибыль

Биржевая цена
1,759.00
Изменение за день
23.00 1.32%
Ежемесячно
0.43%
Ежегодный
28.91%
Q2 прогноз
1,613.20




Валовая прибыль Изменить Дата
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Almirall EUR 429.87M 180.02M 2025-12
Amarin USD 23.17M 961K 2025-12
Amgen USD 6.89B 415M 2025-12
argenx SE USD 1.14B 118.49M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Bayer EUR 5.35B 1.02B 2025-09
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Demant DKK 8.82B 277M 2025-12
Exelixis USD 590.86M 18.68M 2026-03
Fresenius Medical Care EUR 1.18B 210M 2026-03
Galapagos EUR -13.57M 74.82M 2025-09
Genmab DKK 977M 13M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
GN Store Nord DKK 2.5B 344M 2025-12
GRIFOLS EUR 686.84M 56.95M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Insmed USD 217.69M 106.25M 2025-12
Lonza CHF 1.29B 248M 2025-06
Merck EUR 2.96B 252M 2025-12
Novartis USD 10.07B 184M 2026-03
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 3.19B 621M 2025-12